Typhus vaccine

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Typhus vaccine
Vaccine description
Target disease Typhus
Type Killed/Inactivated
Clinical data
ATC code
  • none
 ☒N☑Y (what is this?)   (verify)

Typhus vaccines are vaccines developed to protect against typhus.[1] As of 2017 they are not commercially available.[2][3][4]

One typhus vaccine consists of formaldehyde-inactivated Rickettsia prowazekii. Two doses are injected subcutaneously four weeks apart. Booster doses are required every six to twelve months.

See also


  1. ^ Chattopadhyay S, Richards AL (2007). "Scrub typhus vaccines: past history and recent developments". Hum Vaccin. 3 (3): 73–80. doi:10.4161/hv.3.3.4009. PMID 17375000.
  2. ^ "Epidemic Typhus". www.cdc.gov. 7 March 2017. Retrieved 26 March 2017.
  3. ^ "Murine Typhus". www.cdc.gov. Retrieved 26 March 2017.
  4. ^ "Scrub Typhus". www.cdc.gov. 7 March 2017. Retrieved 26 March 2017.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Typhus_vaccine&oldid=795359441"
This content was retrieved from Wikipedia : http://en.wikipedia.org/wiki/Typhus_vaccine
This page is based on the copyrighted Wikipedia article "Typhus vaccine"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA